These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. A long-term follow-up study of serum lipid levels and coronary heart disease in the elderly. Li JZ; Chen ML; Wang S; Dong J; Zeng P; Hou LW Chin Med J (Engl); 2004 Feb; 117(2):163-7. PubMed ID: 14975195 [TBL] [Abstract][Full Text] [Related]
3. Prevention of coronary heart disease through cholesterol reduction. Grundy SM Am Fam Physician; 1997 May; 55(6):2250-8. PubMed ID: 9149652 [TBL] [Abstract][Full Text] [Related]
4. [Statins in primary prevention of coronary heart disease]. Paulweber B Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004 [TBL] [Abstract][Full Text] [Related]
5. Cholesterol: precursor to many lipid disorders. Jones PH Am J Manag Care; 2001 Aug; 7(9 Suppl):S289-98. PubMed ID: 11517815 [TBL] [Abstract][Full Text] [Related]
6. Total serum cholesterol levels and mortality risk as a function of age. A report based on the Framingham data. Kronmal RA; Cain KC; Ye Z; Omenn GS Arch Intern Med; 1993 May; 153(9):1065-73. PubMed ID: 8481074 [TBL] [Abstract][Full Text] [Related]
7. Lability of serum low-density lipoprotein cholesterol levels during screening in subgroup of Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS) cohort. Clearfield MB; Weis SE; Willis JM; Vasenius KA; McConathy WJ J Am Osteopath Assoc; 2002 Jul; 102(7):377-84. PubMed ID: 12138952 [TBL] [Abstract][Full Text] [Related]
8. Relationship between low cholesterol and disease. Evidence from epidemiological studies and preventive trials. Epstein FH Ann N Y Acad Sci; 1995 Jan; 748():482-90. PubMed ID: 7695190 [TBL] [Abstract][Full Text] [Related]
9. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
10. Cholesterol and cardiovascular disease: how strong is the evidence? LaRosa JC Clin Cardiol; 1992 Nov; 15(11):III2-7; discussion III8-9. PubMed ID: 1458693 [TBL] [Abstract][Full Text] [Related]
11. Correlates and consequences of diffuse atherosclerosis in men with coronary heart disease. Veterans Affairs High-Density Lipoprotein Intervention Trial Study Group. Wilt TJ; Rubins HB; Collins D; O'Connor TZ; Rutan GH; Robins SJ Arch Intern Med; 1996 Jun; 156(11):1181-8. PubMed ID: 8639012 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol, coronary heart disease and stroke: a review of published evidence from observational studies and randomized controlled trials. Huxley R; Lewington S; Clarke R Semin Vasc Med; 2002 Aug; 2(3):315-23. PubMed ID: 16222621 [TBL] [Abstract][Full Text] [Related]
13. [All mortality by cause of death. The challenge of coronary prevention]. Fernández-Cruz A Rev Esp Cardiol; 1998; 51 Suppl 6():23-9. PubMed ID: 10050141 [TBL] [Abstract][Full Text] [Related]
14. Meta-analysis, clinical trials, and transferability of research results into practice. The case of cholesterol-lowering interventions in the secondary prevention of coronary heart disease. Marchioli R; Marfisi RM; Carinci F; Tognoni G Arch Intern Med; 1996 Jun; 156(11):1158-72. PubMed ID: 8639010 [TBL] [Abstract][Full Text] [Related]
16. Total serum cholesterol and ischemic heart disease risk in clinical trials and observational studies. Tyroler HA Am J Prev Med; 1985; 1(4):18-24. PubMed ID: 3916714 [TBL] [Abstract][Full Text] [Related]